Characterization of NTera2/D1 cells as a model system for the investigation of cannabinoid function in human neurons and astrocytes

Journal of Neuroscience Research

Volumn 89, Issue 10, 2011, Pages 1685-1697

  Goodfellow, Catherine E ^a   Graham, Scott E ^a   Dragunow, Mike ^a   Glass, Michelle ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Cannabinoid receptor CB1; Cannabinoid receptor CB2; Central nervous system; Endocannabinoids

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; BETA TUBULIN; BETA TUBULIN 3; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CELL MARKER; CYCLIC AMP; DEXANABINOL; FATTY ACID AMIDASE; FORSKOLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROMODULIN; RETINOIC ACID; RIMONABANT; TAU PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CELL LABELING; CELL STRAIN; CELL STRAIN NT 2A; CELL STRAIN NT 2N; CELL STRAIN NTERA2 D1 CELL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NERVE CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ASTROCYTES; BRAIN CHEMISTRY; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENDOCANNABINOIDS; HUMANS; NEURONS; PHENOTYPE; TERATOCARCINOMA;

EID: 79961210009     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22692     Document Type: Article

References (65)

1. Alger BE. 2002. Retrograde signaling in the regulation of synaptic transmission: focus on endocannabinoids. Prog Neurobiol 68: 247-286.
2. Andrews PW. 1984. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 103: 285-293.
3. Andrews PW, Damjanov I, Simon D, Banting GS, Carlin C, Dracopoli NC, Fogh J. 1984. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50: 147-162.
4. Ashton J, Glass M. 2007. The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol 5: 73-80.
5. Bani-Yaghoub M, Felker JM, Naus CC. 1999. Human NT2/D1 cells differentiate into functional astrocytes. Neuroreport 10: 3843-3846.
6. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. 1997. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277: 1094-1097.
7. Benito C, Nunez E, Tolon RM, Carrier EJ, Rabano A, Hillard CJ, Romero J. 2003. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J Neurosci 23: 11136-11141.
8. Benito C, Romero JP, Tolon RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J. 2007. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis. J Neurosci 27: 2396-2402.
9. Benowitz LI, Routtenberg A. 1997. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci 20: 84-91.
10. Binder LI, Frankfurter A, Rebhun LI. 1985. The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371-1378.
11. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V, Doherty P. 2003. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163: 463-468.
12. Bouaboula M, Bourrie B, Rinaldi-Carmona M, Shire D, Le Fur G, Casellas P. 1995. Stimulation of cannabinoid receptor CB1 induces krox-24 expression in human astrocytoma cells. J Biol Chem 270: 13973-13980.
13. Colton C, Wilt S, Gilbert D, Chernyshev O, Snell J, Dubois-Dalcq M. 1996. Species differences in the generation of reactive oxygen species by microglia. Mol Chem Neuropathol 28: 15-20.
14. Di Marzo V, Bifulco M, De Petrocellis L. 2004. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3: 771-784.
15. Eliasson C, Sahlgren C, Berthold CH, Stakeberg J, Celis JE, Betsholtz C, Eriksson JE, Pekny M. 1999. Intermediate filament protein partnership in astrocytes. J Biol Chem 274: 23996-24006.
16. Gasque P, Jones J, Singhrao SK, Morgan B. 1998. Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense. J Exp Med 187: 451-460.
17. Giuffrida A, Beltramo M, Piomelli D. 2001. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp Ther 298: 7-14.
18. Glass M, Dragunow M, Faull RL. 1997. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 77: 299-318.
19. Graham ES, Angel CE, Schwarcz LE, Dunbar PR, Glass M. 2010. Detailed characterisation of CB2 receptor protein expression in peripheral blood immune cells from healthy human volunteers using flow cytometry. Int J Immunopathol Pharmacol 23: 25-34.
20. Grimsey NL, Goodfellow CE, Scotter EL, Dowie MJ, Glass M, Graham ES. 2008. Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal! J Neurosci Methods 171: 78-86.
21. Grimsey NL, Graham ES, Dragunow M, Glass M. 2010. Cannabinoid Receptor 1 trafficking and the role of the intracellular pool: implications for therapeutics. Biochem Pharmacol 80: 1050-1062.
22. Guibinga GH, Hsu S, Friedmann T. 2010. Deficiency of the housekeeping gene hypoxanthine-guanine phosphoribosyltransferase (HPRT) dysregulates neurogenesis. Mol Ther 18: 54-62.
23. Guillemain I, Alonso G, Patey G, Privat A, Chaudieu I. 2000. Human NT2 neurons express a large variety of neurotransmission phenotypes in vitro. J Comp Neurol 422: 380-395.
24. Guillemain I, Fontes G, Privat A, Chaudieu I. 2003. Early programmed cell death in human NT2 cell cultures during differentiation induced by all-trans-retinoic acid. J Neurosci Res 71: 38-45.
25. Horvath B, Magrid L, Mukhopadhyay P, Batkai S, Rajesh M, Park O, Tanchian G, Gao R, Goodfellow CE, Glass M, Mechoulam R, Pacher P. 2011. A new cannabinoid 2 receptor agonist HU-910 attenuates oxidative stress, inflammation, and cell death associated with hepatic ischemia/reperfusion injury. Br J Pharmacol (in press).
26. Huber G, Matus A. 1984. Differences in the cellular distributions of two microtubule-associated proteins, MAP1 and MAP2, in rat brain. J Neurosci 4: 151-160.
27. Iacovitti L, Stull ND, Jin H. 2001. Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line. Brain Res 912: 99-104.
28. Katsetos CD, Herman MM, Mork SJ. 2003. Class III beta-tubulin in human development and cancer. Cell Motil Cytoskeleton 55: 77-96.
29. Langlois A, Duval D. 1997. Differentiation of the human NT2 cells into neurons and glia. Methods Cell Sci 19: 213-219.
30. Lim JH, Gibbons HM, O'Carroll SJ, Narayan PJ, Faull RL, Dragunow M. 2007. Extracellular signal-regulated kinase involvement in human astrocyte migration. Brain Res 1164: 1-13.
31. Liu M, Hurn PD, Roselli CE, Alkayed NJ. 2007. Role of P450 aromatase in sex-specific astrocytic cell death. J Cereb Blood Flow Metab 27: 135-141.
32. -Delta Delta C(T) method. Methods 25: 402-408.
33. Lu W, Maheshwari A, Misiuta I, Fox SE, Chen N, Zigova T, Christensen RD, Calhoun DA. 2005. Neutrophil-specific chemokines are produced by astrocytic cells but not by neuronal cells. Brain Res Dev Brain Res 155: 127-134.
34. Mailleux P, Parmentier M, Vanderhaeghen JJ. 1992. Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides. Neurosci Lett 143: 200-204.
35. A receptor is expressed in human neurons derived from a teratocarcinoma cell line. Biochem Biophys Res Commun 237: 719-723.
36. McPartland JM, Glass M, Pertwee RG. 2007. Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences. Br J Pharmacol 152: 583-593.
37. Milton NG. 2002. Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. Neurosci Lett 332: 127-130.
38. Navarrete M, Araque A. 2008. Endocannabinoids mediate neuron-astrocyte communication. Neuron 57: 883-893.
39. Navarrete M, Araque A. 2010. Endocannabinoids potentiate synaptic transmission through stimulation of astrocytes. Neuron 68: 113-126.
40. Neary JT, McCarthy M, Kang Y, Zuniga S. 1998. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures. Neurosci Lett 242: 159-162.
41. Oberheim NA, Wang X, Goldman S, Nedergaard M. 2006. Astrocytic complexity distinguishes the human brain. Trends Neurosci 29: 547-553.
42. Oberheim NA, Takano T, Han X, He W, Lin JH, Wang F, Xu Q, Wyatt JD, Pilcher W, Ojemann JG, Ransom BR, Goldman SA, Nedergaard M. 2009. Uniquely hominid features of adult human astrocytes. J Neurosci 29: 3276-3287.
43. Ozdener H. 2007. Inducible functional expression of Bcl-2 in human astrocytes derived from NTera-2 cells. J Neurosci Methods 159: 8-18.
44. Palazuelos J, Aguado T, Egia A, Mechoulam R, Guzman M, Galve-Roperh I. 2006. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. FASEB J 20: 2405-2407.
45. Pekny M, Pekna M. 2004. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol 204: 428-437.
46. Piontek J, Regnier-Vigouroux A, Brandt R. 2002. Contact with astroglial membranes induces axonal and dendritic growth of human CNS model neurons and affects the distribution of the growth-associated proteins MAP1B and GAP43. J Neurosci Res 67: 471-483.
47. Pistritto G, Papacleovoulou G, Ragone G, Di Cesare S, Papaleo V, Mason JI, Barbaccia ML. 2009. Differentiation-dependent progesterone synthesis and metabolism in NT2-N human neurons. Exp Neurol 217: 302-311.
48. Pleasure SJ, Page C, Lee VM. 1992. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12: 1802-1815.
49. Podrygajlo G, Tegenge MA, Gierse A, Paquet-Durand F, Tan S, Bicker G, Stern M. 2009. Cellular phenotypes of human model neurons (NT2) after differentiation in aggregate culture. Cell Tissue Res 336: 439-452.
50. Rivers JR, Ashton JC. 2010. The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies. Cent Nerv Syst Agents Med Chem 10: 47-64.
51. Rochette-Egly C, Germain P. 2009. Dynamic and combinatorial control of gene expression by nuclear retinoic acid receptors (RARs). Nucl Recept Signal 7: e005.
52. Rodriguez JJ, Mackie K, Pickel VM. 2001. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat caudate putamen nucleus. J Neurosci 21: 823-833.
53. Saha RN, Pahan K. 2006. Signals for the induction of nitric oxide synthase in astrocytes. Neurochem Int 49: 154-163.
54. Sakolsky DJ, Ashby B. 2000. Determination of D1 and D2 dopamine receptor expression by Ntera-2 cells. Brain Res Mol Brain Res 84: 158-161.
55. Sanchez C, Galve-Roperh I, Rueda D, Guzman M. 1998. Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol 54: 834-843.
56. Sanchez MC, Benitez A, Ortloff L, Green LM. 2009. Alterations in glutamate uptake in NT2-derived neurons and astrocytes after exposure to gamma radiation. Radiat Res 171: 41-52.
57. Sandhu JK, Sikorska M, Walker PR. 2002. Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells. J Neurosci Res 68: 604-614.
58. Sandhu JK, Pandey S, Ribecco-Lutkiewicz M, Monette R, Borowy-Borowski H, Walker PR, Sikorska M. 2003. Molecular mechanisms of glutamate neurotoxicity in mixed cultures of NT2-derived neurons and astrocytes: protective effects of coenzyme Q10. J Neurosci Res 72: 691-703.
59. Sodja C, Fang H, Dasgupta T, Ribecco M, Walker PR, Sikorska M. 2002. Identification of functional dopamine receptors in human teratocarcinoma NT2 cells. Brain Res Mol Brain Res 99: 83-91.
60. 2+ in response to muscarinic and glutamate receptor agonists during the differentiation of NTERA2 human embryonal carcinoma cells into neurons. Eur J Neurosci 8: 783-793.
61. Stewart R, Christie VB, Przyborski SA. 2003. Manipulation of human pluripotent embryonal carcinoma stem cells and the development of neural subtypes. Stem Cells 21: 248-256.
62. Tegenge MA, Bicker G. 2009. Nitric oxide and cGMP signal transduction positively regulates the motility of human neuronal precursor (NT2) cells. J Neurochem 110: 1828-1841.
63. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
64. Walter L, Franklin A, Witting A, Moller T, Stella N. 2002. Astrocytes in culture produce anandamide and other acylethanolamides. J Biol Chem 277: 20869-20876.
65. Zigova T, Barroso LF, Willing AE, Saporta S, McGrogan MP, Freeman TB, Sanberg PR. 2000. Dopaminergic phenotype of hNT cells in vitro. Brain Res Dev Brain Res 122: 87-90.